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A significant incidence of cancer (24.5%) was found in men with a serum PSA between 2.5 and 4.0 ng/mL; 67.6% of the cancers were significant. A modification of the Gleason scoring system for men with Gleason 7 disease revealed a difference in outcome after radical prostatectomy. Artificial neural network models can be developed and used to better predict patient outcome when pathologic and clinical features are known.
